
Hemex
AI Verified
Switzerland
Family Office
14 Grammetstrasse, 4410 Liestal, Canton of Basel-Landschaft, Switzerland
2011
Criteria | Requirements | Match |
---|---|---|
Regions | Northern Europe, Western Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Seed, Series A, Series B, Pre-Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
Hemex operates as a specialized Contract Research Organization that collaborates with European biotechnology and medical technology enterprises to streamline their product clinical development processes. Strategically headquartered in Basel, Switzerland—a renowned life sciences center—with additional operations in Germany, Benelux countries, and Colombia, the organization is ideally positioned to coordinate and execute multinational clinical trials and research initiatives across diverse geographic regions.
The company delivers a comprehensive range of clinical development services, encompassing rigorous quality management systems and expert regulatory guidance. Hemex distinguishes itself through its commitment to transparent communication and accessibility, maintaining close proximity to clients while ensuring all project stakeholders remain informed throughout the development lifecycle. This client-centric approach enables more efficient decision-making and helps navigate the complex regulatory landscapes across different markets.
With deep expertise in European regulatory frameworks and clinical trial management, Hemex has established itself as a valuable partner for emerging and established life science companies seeking to advance their innovations through clinical validation. The organization's multinational presence allows it to leverage local knowledge and relationships with clinical sites, regulatory authorities, and healthcare systems across multiple jurisdictions, providing clients with streamlined access to diverse patient populations and markets.
Hemex's collaborative methodology emphasizes working alongside clients rather than simply for them, creating integrated teams that align closely with each company's specific objectives and timelines. This partnership model has proven particularly valuable for biotechnology and medical device developers navigating the critical phases between preclinical research and market approval. By providing tailored support throughout the clinical development journey, Hemex enables its clients to optimize resource allocation, accelerate development timelines, and ultimately increase their chances of bringing innovative healthcare solutions to patients.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
Hemex maintains its global headquarters in Switzerland, serving as the strategic center for its operations. The company's primary corporate offices are located at 14 Grammetstrasse, 4410 Liestal, Canton of Basel-Landschaft, Switzerland.
Hemex focuses its investment activities on companies operating in the following stages: Seed, Series A, Series B, Pre-Seed. Hemex provides strategic capital and expertise to support promising businesses at these critical phases of development.
Hemex maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Northern Europe, Western Europe.
Hemex was established in 2011, marking the beginning of its journey as an investment firm.
Hemex is the following type of investment firm: Family Office. The organization provides capital and strategic support to entrepreneurs and growing companies.